ONESOURCE SPECIALTY PHARMA
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Income Statement History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| INCOME : | |||
| Gross Sales | ₹1,307 Cr | ₹172 Cr | ₹39 Cr |
| Sales | ₹636 Cr | - | - |
| Job Work/ Contract Receipts | - | - | - |
| Processing Charges / Service Income | ₹672 Cr | ₹172 Cr | ₹39 Cr |
| Revenue from property development | - | - | - |
| Other Operational Income | - | - | - |
| Less: Excise Duty | - | - | - |
| Net Sales | ₹1,300 Cr | ₹172 Cr | ₹39 Cr |
| EXPENDITURE : | |||
| Increase/Decrease in Stock | ₹2.61 Cr | - | - |
| Raw Material Consumed | ₹406 Cr | ₹71 Cr | ₹22 Cr |
| Opening Raw Materials | ₹73 Cr | ₹73 Cr | - |
| Purchases Raw Materials | ₹437 Cr | ₹70 Cr | ₹95 Cr |
| Closing Raw Materials | ₹104 Cr | ₹73 Cr | ₹73 Cr |
| Other Direct Purchases / Brought in cost | - | - | - |
| Other raw material cost | - | - | - |
| Power & Fuel Cost | ₹38 Cr | ₹21 Cr | ₹21 Cr |
| Electricity & Power | ₹36 Cr | ₹20 Cr | ₹20 Cr |
| Oil, Fuel & Natural gas | ₹0.02 Cr | ₹0.13 Cr | - |
| Coals etc | - | - | - |
| Other power & fuel | ₹2.18 Cr | ₹0.29 Cr | ₹0.46 Cr |
| Employee Cost | ₹215 Cr | ₹79 Cr | ₹73 Cr |
| Salaries, Wages & Bonus | ₹184 Cr | ₹68 Cr | ₹56 Cr |
| Contributions to EPF & Pension Funds | ₹13 Cr | ₹4.42 Cr | ₹3.36 Cr |
| Workmen and Staff Welfare Expenses | ₹13 Cr | ₹4.82 Cr | ₹7.07 Cr |
| Other Employees Cost | ₹4.31 Cr | ₹1.96 Cr | ₹5.96 Cr |
| Other Manufacturing Expenses | ₹68 Cr | ₹17 Cr | ₹17 Cr |
| Sub-contracted / Out sourced services | - | - | - |
| Processing Charges | ₹6.88 Cr | ₹2.60 Cr | ₹3.56 Cr |
| Repairs and Maintenance | ₹62 Cr | ₹15 Cr | ₹13 Cr |
| Packing Material Consumed | - | - | - |
| Other Mfg Exp | - | - | - |
| General and Administration Expenses | ₹183 Cr | ₹64 Cr | ₹47 Cr |
| Rent , Rates & Taxes | ₹24 Cr | ₹12 Cr | ₹1.96 Cr |
| Insurance | ₹4.39 Cr | ₹4.49 Cr | ₹5.22 Cr |
| Printing and stationery | ₹1.52 Cr | ₹0.64 Cr | ₹0.65 Cr |
| Professional and legal fees | ₹87 Cr | ₹15 Cr | ₹17 Cr |
| Traveling and conveyance | ₹3.72 Cr | ₹0.91 Cr | ₹1.15 Cr |
| Other Administration | ₹62 Cr | ₹31 Cr | ₹21 Cr |
| Selling and Distribution Expenses | ₹16 Cr | ₹0.90 Cr | ₹9.33 Cr |
| Advertisement & Sales Promotion | ₹1.82 Cr | ₹0.50 Cr | ₹1.04 Cr |
| Sales Commissions & Incentives | - | - | - |
| Freight and Forwarding | ₹15 Cr | ₹0.40 Cr | ₹8.29 Cr |
| Handling and Clearing Charges | - | - | - |
| Other Selling Expenses | - | - | - |
| Miscellaneous Expenses | ₹2.99 Cr | ₹6.84 Cr | ₹11 Cr |
| Bad debts /advances written off | - | ₹0.07 Cr | ₹0.53 Cr |
| Provision for doubtful debts | ₹0.83 Cr | - | - |
| Losson disposal of fixed assets(net) | ₹0.23 Cr | ₹5.81 Cr | - |
| Losson foreign exchange fluctuations | - | ₹0.56 Cr | ₹9.16 Cr |
| Losson sale of non-trade current investments | - | - | - |
| Other Miscellaneous Expenses | ₹1.94 Cr | ₹0.40 Cr | ₹1.48 Cr |
| Less: Expenses Capitalised | - | - | - |
| Total Expenditure | ₹932 Cr | ₹259 Cr | ₹199 Cr |
| Operating Profit (Excl OI) | ₹367 Cr | ₹-88 Cr | ₹-161 Cr |
| Other Income | ₹20 Cr | ₹4.23 Cr | ₹2.70 Cr |
| Interest Received | ₹15 Cr | ₹1.77 Cr | ₹1.48 Cr |
| Dividend Received | - | - | - |
| Profit on sale of Fixed Assets | - | - | ₹0.90 Cr |
| Profits on sale of Investments | ₹1.12 Cr | ₹0.76 Cr | ₹0.12 Cr |
| Provision Written Back | - | - | ₹0.01 Cr |
| Foreign Exchange Gains | ₹2.01 Cr | - | - |
| Others | ₹1.41 Cr | ₹1.70 Cr | ₹0.20 Cr |
| Operating Profit | ₹387 Cr | ₹-83 Cr | ₹-158 Cr |
| Interest | ₹162 Cr | ₹89 Cr | ₹48 Cr |
| InterestonDebenture / Bonds | - | - | - |
| Interest on Term Loan | ₹135 Cr | ₹64 Cr | ₹37 Cr |
| Intereston Fixed deposits | - | - | - |
| Bank Charges etc | ₹3.91 Cr | ₹4.04 Cr | ₹7.44 Cr |
| Other Interest | ₹22 Cr | ₹22 Cr | ₹3.31 Cr |
| PBDT | ₹225 Cr | ₹-173 Cr | ₹-205 Cr |
| Depreciation | ₹135 Cr | ₹76 Cr | ₹66 Cr |
| Profit Before Taxation & Exceptional Items | ₹91 Cr | ₹-249 Cr | ₹-271 Cr |
| Exceptional Income / Expenses | ₹-112 Cr | ₹-116 Cr | ₹-158 Cr |
| Profit Before Tax | ₹-21 Cr | ₹-365 Cr | ₹-430 Cr |
| Provision for Tax | ₹-41 Cr | - | - |
| Current Income Tax | - | - | - |
| Deferred Tax | ₹-41 Cr | - | - |
| Other taxes | - | - | - |
| Profit After Tax | ₹20 Cr | ₹-365 Cr | ₹-430 Cr |
| Extra items | ₹-0.69 Cr | ₹-25 Cr | ₹-370 Cr |
| Adjustments to PAT | - | - | - |
| Profit Balance B/F | ₹-1,818 Cr | ₹-1,427 Cr | ₹-629 Cr |
| Appropriations | ₹-1,799 Cr | ₹-1,818 Cr | ₹-1,428 Cr |
| General Reserves | - | - | - |
| Proposed Equity Dividend | - | - | - |
| Corporate dividend tax | - | - | - |
| Other Appropriation | ₹2.97 Cr | ₹0.53 Cr | ₹-0.48 Cr |
| Equity Dividend % | - | - | - |
| Earnings Per Share | ₹1.75 | ₹-91.01 | ₹-107.12 |
| Adjusted EPS | ₹1.75 | ₹-91.01 | ₹-107.12 |
Compare Income Statement of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹20,505.8 Cr | -4.5% | -3.8% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,287.0 Cr | -0.6% | 4% | -6.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹177,657.0 Cr | -1.7% | 9.3% | 12.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,202.0 Cr | 5.2% | 7% | 11.9% | Stock Analytics | |
| CIPLA | ₹122,276.0 Cr | 0.1% | 1.3% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,024.0 Cr | 0.2% | -2.9% | -4.9% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | -4.5% |
-3.8% |
|
| SENSEX | -0.5% |
2% |
4.8% |
You may also like the below Video Courses